No specific molecular drug target identified

The designation 'No specific molecular drug target identified' serves as a placeholder in pharmacological databases to indicate that a drug's therapeutic effect cannot be attributed to a single, defined molecular entity (DrugBank Online, 2024). This classification is typically used for agents that act through non-specific chemical or physical mechanisms, such as antacids that neutralize gastric acid or osmotic diuretics that alter fluid balance (Goodman & Gilman's The Pharmacological Basis of Therapeutics). It may also be applied to complex botanical or biological mixtures where the active constituents and their respective binding sites remain uncharacterized. In the field of drug discovery, this status often implies that the compound was identified via phenotypic screening rather than a target-centric approach (Nature Reviews Drug Discovery, 2011). While such drugs can be highly effective, the absence of a known target poses significant challenges for optimizing drug-like properties and predicting potential off-target toxicities. As scientific understanding evolves, many substances previously categorized this way are eventually linked to specific proteins or pathways through advanced proteomic and genomic techniques.

Other names

Unknown targetUnidentified targetNon-specific mechanism of actionTarget unknown

The mechanism of action involves non-specific physical or chemical interactions, such as neutralization of acid, osmotic gradient shifts, or adsorption, rather than binding to a specific protein receptor or enzyme.